使IL-8

Wei Zhang1, Lihua Pan2, Xiaoliang Wu3

  • 1Lemole Center for Integrated Lymphatic and Vascular Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA; Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, USA.

Vascular pharmacology
|November 1, 2024
PubMed
概括

介乐-8 (IL-8) 通过在血管损伤后加剧新极度增生症来驱动心血管疾病. 中和IL-8显著减少了neointima的形成,证实了它在这个过程中的作用.